XML 86 R71.htm IDEA: XBRL DOCUMENT v3.26.1
License, Collaboration, and Other Arrangements - BioInvent License Agreement (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Sep. 17, 2025
May 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Asset Acquisition        
Closing cash payment for intangible assets     $ 20,725  
Closing cash payment $ 98,968      
Transaction costs $ 708      
Amortization of intangible assets     2,961 $ 206
BioInvent License Agreement        
Asset Acquisition        
Closing cash payment for intangible assets   $ 20,000    
Contingent consideration   $ 10,000 10,000  
Transaction costs     $ 700  
Estimated useful life of intangible asset     15 years 6 months  
Amortization of intangible assets     $ 800  
Impairment of intangible asset     $ 0